ATLATL and Samsung Bioepis Launch 'Samsung Bioepis Innovation Prize C-Lab Outside' to Accelerate Early-Stage Biotech Innovation Across Asia-Pacific
ATLATL and Samsung Bioepis have launched an innovation prize to support early-stage biotech startups in the Asia-Pacific region. The program provides winners with laboratory infrastructure and mentorship to accelerate therapeutic development.
Why it matters
Encourages scientific advancement and commercialization of new medical technologies by bridging the gap between research and industry support.
Applications Open June 25 for Early-Stage Biotech Companies Developing Next-Generation Therapeutics and Platform Technologies
This is a standard corporate press release regarding a business and science initiative.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in